The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Geriatric Medicines-Global Market Insights and Sales Trends 2024
Synopsis
Geriatric medicine is a growing medical specialty that focuses on the care and treatment of older people.
The global Geriatric Medicines market size is expected to reach US$ 1150460 million by 2029, growing at a CAGR of 7.1% from 2023 to 2029. The market is mainly driven by the significant applications of Geriatric Medicines in various end use industries. The expanding demands from the Cardiovascular diseases, Arthritis, Neurological Disorders and Cancer, are propelling Geriatric Medicines market. Analgesics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Antihypertensives segment is estimated at % CAGR for the next seven-year period.
The Geriatric Medicines market is witnessing substantial growth due to the global increase in the elderly population. With aging, individuals are prone to chronic diseases and conditions, leading to a higher demand for geriatric medicines. Pharmaceutical companies are focusing on developing medications that address age-related health issues like cardiovascular diseases, arthritis, dementia, and diabetes. The market is also driven by advancements in medical research, personalized medicine, and improved healthcare access for the elderly. However, challenges exist in terms of ensuring medication safety, addressing polypharmacy concerns, and affordability for older adults. Despite these challenges, the Geriatric Medicines market presents significant opportunities for pharmaceutical companies to cater to the healthcare needs of an aging population.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Geriatric Medicines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Geriatric Medicines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Geriatric Medicines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Geriatric Medicines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Geriatric Medicines covered in this report include Eli Lilly and Company, AstraZeneca, Boehringer Ingelheim, Abbott Laboratories, Sanofi, Bristol-Myers Squibb, Merck, Novartis and Pfizer, etc.
The global Geriatric Medicines market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eli Lilly and Company
AstraZeneca
Boehringer Ingelheim
Abbott Laboratories
Sanofi
Bristol-Myers Squibb
Merck
Novartis
Pfizer
GSK
Global Geriatric Medicines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Geriatric Medicines market, Segment by Type:
Analgesics
Antihypertensives
Statins
Antidiabetics
Proton Pump Inhibitor
Anticoagulant
Antipsychotics
Antidepressants
Global Geriatric Medicines market, by Application
Cardiovascular diseases
Arthritis
Neurological Disorders
Cancer
Osteoporosis
Respiratory
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Geriatric Medicines companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Geriatric medicine is a growing medical specialty that focuses on the care and treatment of older people.
The global Geriatric Medicines market size is expected to reach US$ 1150460 million by 2029, growing at a CAGR of 7.1% from 2023 to 2029. The market is mainly driven by the significant applications of Geriatric Medicines in various end use industries. The expanding demands from the Cardiovascular diseases, Arthritis, Neurological Disorders and Cancer, are propelling Geriatric Medicines market. Analgesics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Antihypertensives segment is estimated at % CAGR for the next seven-year period.
The Geriatric Medicines market is witnessing substantial growth due to the global increase in the elderly population. With aging, individuals are prone to chronic diseases and conditions, leading to a higher demand for geriatric medicines. Pharmaceutical companies are focusing on developing medications that address age-related health issues like cardiovascular diseases, arthritis, dementia, and diabetes. The market is also driven by advancements in medical research, personalized medicine, and improved healthcare access for the elderly. However, challenges exist in terms of ensuring medication safety, addressing polypharmacy concerns, and affordability for older adults. Despite these challenges, the Geriatric Medicines market presents significant opportunities for pharmaceutical companies to cater to the healthcare needs of an aging population.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Geriatric Medicines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Geriatric Medicines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Geriatric Medicines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Geriatric Medicines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Geriatric Medicines covered in this report include Eli Lilly and Company, AstraZeneca, Boehringer Ingelheim, Abbott Laboratories, Sanofi, Bristol-Myers Squibb, Merck, Novartis and Pfizer, etc.
The global Geriatric Medicines market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eli Lilly and Company
AstraZeneca
Boehringer Ingelheim
Abbott Laboratories
Sanofi
Bristol-Myers Squibb
Merck
Novartis
Pfizer
GSK
Global Geriatric Medicines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Geriatric Medicines market, Segment by Type:
Analgesics
Antihypertensives
Statins
Antidiabetics
Proton Pump Inhibitor
Anticoagulant
Antipsychotics
Antidepressants
Global Geriatric Medicines market, by Application
Cardiovascular diseases
Arthritis
Neurological Disorders
Cancer
Osteoporosis
Respiratory
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Geriatric Medicines companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Geriatric Medicines
1.1 Geriatric Medicines Market Overview
1.1.1 Geriatric Medicines Product Scope
1.1.2 Geriatric Medicines Market Status and Outlook
1.2 Global Geriatric Medicines Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Geriatric Medicines Market Size by Region (2018-2029)
1.4 Global Geriatric Medicines Historic Market Size by Region (2018-2023)
1.5 Global Geriatric Medicines Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Geriatric Medicines Market Size (2018-2029)
1.6.1 North America Geriatric Medicines Market Size (2018-2029)
1.6.2 Europe Geriatric Medicines Market Size (2018-2029)
1.6.3 Asia-Pacific Geriatric Medicines Market Size (2018-2029)
1.6.4 Latin America Geriatric Medicines Market Size (2018-2029)
1.6.5 Middle East & Africa Geriatric Medicines Market Size (2018-2029)
2 Geriatric Medicines Market by Type
2.1 Introduction
2.1.1 Analgesics
2.1.2 Antihypertensives
2.1.3 Statins
2.1.4 Antidiabetics
2.1.5 Proton Pump Inhibitor
2.1.6 Anticoagulant
2.1.7 Antipsychotics
2.1.8 Antidepressants
2.2 Global Geriatric Medicines Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Geriatric Medicines Historic Market Size by Type (2018-2023)
2.2.2 Global Geriatric Medicines Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Geriatric Medicines Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Geriatric Medicines Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Geriatric Medicines Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Geriatric Medicines Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Geriatric Medicines Revenue Breakdown by Type (2018-2029)
3 Geriatric Medicines Market Overview by Application
3.1 Introduction
3.1.1 Cardiovascular diseases
3.1.2 Arthritis
3.1.3 Neurological Disorders
3.1.4 Cancer
3.1.5 Osteoporosis
3.1.6 Respiratory
3.1.7 Other
3.2 Global Geriatric Medicines Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Geriatric Medicines Historic Market Size by Application (2018-2023)
3.2.2 Global Geriatric Medicines Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Geriatric Medicines Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Geriatric Medicines Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Geriatric Medicines Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Geriatric Medicines Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Geriatric Medicines Revenue Breakdown by Application (2018-2029)
4 Geriatric Medicines Competition Analysis by Players
4.1 Global Geriatric Medicines Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Geriatric Medicines as of 2022)
4.3 Date of Key Players Enter into Geriatric Medicines Market
4.4 Global Top Players Geriatric Medicines Headquarters and Area Served
4.5 Key Players Geriatric Medicines Product Solution and Service
4.6 Competitive Status
4.6.1 Geriatric Medicines Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Eli Lilly and Company
5.1.1 Eli Lilly and Company Profile
5.1.2 Eli Lilly and Company Main Business
5.1.3 Eli Lilly and Company Geriatric Medicines Products, Services and Solutions
5.1.4 Eli Lilly and Company Geriatric Medicines Revenue (US$ Million) & (2018-2023)
5.1.5 Eli Lilly and Company Recent Developments
5.2 AstraZeneca
5.2.1 AstraZeneca Profile
5.2.2 AstraZeneca Main Business
5.2.3 AstraZeneca Geriatric Medicines Products, Services and Solutions
5.2.4 AstraZeneca Geriatric Medicines Revenue (US$ Million) & (2018-2023)
5.2.5 AstraZeneca Recent Developments
5.3 Boehringer Ingelheim
5.3.1 Boehringer Ingelheim Profile
5.3.2 Boehringer Ingelheim Main Business
5.3.3 Boehringer Ingelheim Geriatric Medicines Products, Services and Solutions
5.3.4 Boehringer Ingelheim Geriatric Medicines Revenue (US$ Million) & (2018-2023)
5.3.5 Abbott Laboratories Recent Developments
5.4 Abbott Laboratories
5.4.1 Abbott Laboratories Profile
5.4.2 Abbott Laboratories Main Business
5.4.3 Abbott Laboratories Geriatric Medicines Products, Services and Solutions
5.4.4 Abbott Laboratories Geriatric Medicines Revenue (US$ Million) & (2018-2023)
5.4.5 Abbott Laboratories Recent Developments
5.5 Sanofi
5.5.1 Sanofi Profile
5.5.2 Sanofi Main Business
5.5.3 Sanofi Geriatric Medicines Products, Services and Solutions
5.5.4 Sanofi Geriatric Medicines Revenue (US$ Million) & (2018-2023)
5.5.5 Sanofi Recent Developments
5.6 Bristol-Myers Squibb
5.6.1 Bristol-Myers Squibb Profile
5.6.2 Bristol-Myers Squibb Main Business
5.6.3 Bristol-Myers Squibb Geriatric Medicines Products, Services and Solutions
5.6.4 Bristol-Myers Squibb Geriatric Medicines Revenue (US$ Million) & (2018-2023)
5.6.5 Bristol-Myers Squibb Recent Developments
5.7 Merck
5.7.1 Merck Profile
5.7.2 Merck Main Business
5.7.3 Merck Geriatric Medicines Products, Services and Solutions
5.7.4 Merck Geriatric Medicines Revenue (US$ Million) & (2018-2023)
5.7.5 Merck Recent Developments
5.8 Novartis
5.8.1 Novartis Profile
5.8.2 Novartis Main Business
5.8.3 Novartis Geriatric Medicines Products, Services and Solutions
5.8.4 Novartis Geriatric Medicines Revenue (US$ Million) & (2018-2023)
5.8.5 Novartis Recent Developments
5.9 Pfizer
5.9.1 Pfizer Profile
5.9.2 Pfizer Main Business
5.9.3 Pfizer Geriatric Medicines Products, Services and Solutions
5.9.4 Pfizer Geriatric Medicines Revenue (US$ Million) & (2018-2023)
5.9.5 Pfizer Recent Developments
5.10 GSK
5.10.1 GSK Profile
5.10.2 GSK Main Business
5.10.3 GSK Geriatric Medicines Products, Services and Solutions
5.10.4 GSK Geriatric Medicines Revenue (US$ Million) & (2018-2023)
5.10.5 GSK Recent Developments
6 North America
6.1 North America Geriatric Medicines Market Size by Country (2018-2029)
6.2 the United States
6.3 Canada
7 Europe
7.1 Europe Geriatric Medicines Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Geriatric Medicines Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Geriatric Medicines Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Geriatric Medicines Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Geriatric Medicines Market Dynamics
11.1 Geriatric Medicines Industry Trends
11.2 Geriatric Medicines Market Drivers
11.3 Geriatric Medicines Market Challenges
11.4 Geriatric Medicines Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
